AAIC Submissions

Information on presentation types, themes and topics.

On This Page:

Presentation Types

Authors may select from three presentation formats when submitting an abstract for AAIC. These include:

AAIC Poster Presentation (individual)

AAIC Oral Presentation (individual)

AAIC Featured Research Session (FRS)

AAIC Travel Fellowships

A limited number of travel fellowships are available to AAIC presenting authors. Awarded in various packages, AAIC Travel Fellowships may include one, two or three of the following: complimentary AAIC registration, housing and/or airfare support.

Application process: In order to apply, the applicant must be indicated as the presenting author on a submitted abstract for AAIC and complete the travel fellowship application requirements in the last step of the abstract submission process. Learn more.

Themes, Topics and Subtopics

Selection of a theme, topic and subtopic for the abstract allows submitters to "self-identify" the area in which the abstract best fits. This identification is the first step in sorting abstracts for the Scientific Program Committee, who will take this identification into consideration and group related abstracts with similar topics into the same session. Selection of a primary theme, topic and subtopic is required.

AAIC Abstract Submission Themes
  • Theme
  • Topics
  • Subtopics

Basic and Translational Science

Development of New Models and Analysis Methods

  • α-synuclein
  • Amyloid/Abeta
  • Behavioral models
  • Neuroinflammation
  • Novel assays and technologies
  • Screening studies/platforms
  • Seeding and spreading of proteinopathies
  • Tau
  • TDP-43
  • Validation of pre-clinical methods


  • Atypical and other dementias
  • Endophenotypes
  • Omics and systems biology
  • Genetic factors of Alzheimer's disease
  • Genetic factors of non-Alzheimer's tauopathies
  • Genetics of cognitive aging
  • Molecular genetics

Molecular and Cell Biology

  • α-synuclein
  • APP/Abeta/Amyloid
  • Axonal transport
  • Calcium homeostasis
  • Cell cycle disruption
  • Endosomal-lysosomal dysfunction
  • Enzyme activities
  • Mitochondrial function/energetics
  • Neurodegeneration and neuroprotection
  • Neurofibrillary degeneration
  • Neuroinflammation
  • Neuronal cell death mechanisms (i.e. apoptosis)
  • Neurotrophin mechanisms
  • Others
  • Oxidative stress
  • Presenilins
  • Protein clearance/recycling
  • Receptors
  • Signal transduction
  • Stem Cells, IPS cells
  • Synaptic disruption
  • Tau
  • TDP-43
  • Vascular factors

Protein-Protein interactions

  • No subtopics

  • Theme
  • Topics
  • Subtopics

Diagnosis and Prognosis

Biomarkers (non-neuroimaging)

  • Differential diagnosis
  • Longitudinal change over time
  • Method development and/or quality control
  • Multi-modal comparisons
  • Novel biomarkers
  • Plasma/serum/urine biomarkers
  • Prognostic utility
  • Use in clinical trial design and evaluation

Clinical (neuropsychiatry and behavioral neurology)

  • Assessment/measurement of neuropsychiatric/behavioral and psychological symptoms
  • Behavioral neurology
  • Dementia
  • Mild cognitive impairment/early symptomatic disease
  • Neuropsychiatry
  • Non-pharmacologic interventions
  • Presymptomatic disease/prodromal disease/prodromal states
  • Treatment development and clinical trials


  • Animal imaging
  • Differential diagnosis
  • Evaluating treatments
  • Imaging and genetics
  • Multi-modal comparisons
  • New imaging methods
  • Normal brain aging
  • Optimal neuroimaging measures for early detection
  • Optimal neuroimaging measures for tracking disease progression


  • Alpha-synuclein
  • Amyloid
  • Clinico-pathologic correlations
  • Etiopathogenesis--links to brain disease
  • Imaging-pathologic correlations
  • Novel methods
  • Other
  • Proteinopathies
  • Selective vulnerability
  • Tau
  • Topography of pathology
  • Vascular


  • Computerized neuropsychological assessment
  • Early detection of cognitive decline with neuropsychological tests
  • Multicultural issues in assessment of dementia
  • Neuropsychological correlates of physiologic markers of cognitive decline/dementia
  • Neuropsychological profiles of dementia: Valid biomarkers?
  • Normal cognitive aging

  • Theme
  • Topics
  • Subtopics

Public Health and Psychosocial

Dementia Care Research
(research projects; nonpharmacological)

  • Assessment and care planning
  • Behavioral interventions
  • Community care
  • Cross-cultural studies and cultural/linguistic adaptations
  • Family/lay caregiving
  • Instrument development, program evaluation and translation
  • Long-term care
  • Use of technologies
  • Therapeutic strategies and interventions

Dementia Care Practice

  • Innovative programs and practices
  • Leadership and staff development
  • Policy and systems change
  • Program evaluation and care interventions


  • Innovative methods in epidemiology (i.e. assessment methods, design, recruitment strategies, statistical methods, etc.)
  • Prevalence, incidence, and outcomes of MCI and dementia
  • Risk and protective factors in MCI and dementia

Health Economics and Policy

  • Cost-effectiveness of treatment/prevention and diagnosis
  • Cost of care
  • Policy and plans
  • Services


  • Cognitive interventions
  • Exercise
  • Lifestyle factors (e.g., smoking, etc.)
  • Multidomain
  • Nutrition
  • Other

Psychosocial Factors and Environmental Design

  • Environmental design and technology
  • Living with dementia and quality of life
  • Social networks

  • Theme
  • Topics
  • Subtopics



  • Human trials: Cognitive enhancement
  • Human trials: Nutraceuticals and non-pharmacological interventions
  • Human trials: Other behavioral symptoms
  • Human trials: Anti-amyloid
  • Human trials: Anti-tau
  • Human trials: Inflammation
  • Human trials: Other
  • Novel outcomes measures
  • Prevention (clinical)
  • Trial design


  • Lead optimization studies
  • Natural products and nutraceuticals
  • Non-pharmacological interventions
  • Novel screening strategies
  • Target identification and validation studies: Amyloid
  • Target identification and validation studies: Cognitive enhancement and other behavioral symptoms
  • Target identification and validation studies: Inflammation and innate immunity
  • Target identification and validation studies: Neuronal and synaptic protection
  • Target identification and validation studies: Other
  • Target identification and validation studies: Proteostasis
  • Target identification and validation studies: Tau

Join the Conversation #AAIC19






> 1200px
> 992px
> 768px
< 767px